Correlations Between MRI Biomarkers PDFF and cT1 With Histopathological Features of Non-Alcoholic Steatohepatitis

INTRODUCTION: Late stage clinical trials in non-alcoholic steatohepatitis (NASH) are currently required by the FDA to use liver biopsy as a primary endpoint. The well-reported limitations with biopsy, such as associated risks and sampling error, coupled with patient preference, are driving investiga...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Endocrinol (Lausanne)
Autors principals: Dennis, Andrea, Kelly, Matt D., Fernandes, Carolina, Mouchti, Sofia, Fallowfield, Jonathan A., Hirschfield, Gideon, Pavlides, Michael, Harrison, Stephen, Chakravarthy, Manu V., Banerjee, Rajarshi, Sanyal, Arun
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2021
Matèries:
Endocrinology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7877451/
https://ncbi.nlm.nih.gov/pubmed/33584535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2020.575843
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars